Pair Name | Sulforaphane, Acetazolamide | ||
Phytochemical Name | Sulforaphane (PubChem CID: 5350 ) | ||
Anticancer drug Name | Acetazolamide (PubChem CID: 1986 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sulforaphane, Acetazolamide | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | NANOGNB | hsa360030 |
Down-regulation | Expression | POU5F1 | hsa5460 | |
Down-regulation | Expression | SOX2 | hsa6657 | |
In Vitro Model | NCI-H727 | Lung carcinoid tumor | Homo sapiens (Human) | CVCL_1584 |
NCI-H720 | Lung carcinoid tumor | Homo sapiens (Human) | CVCL_1583 | |
In Vivo Model | H727 and H720 parental and 3rd generation spheroid cells (3×10⁴) were injected into the subcutaneous inguinal fat pad of NOD/SCID mice. | |||
Result | Human bronchial carcinoid tumor cells serially passaged as spheroids contain a higher fraction of TIC exhibiting a stemness phenotype. This TIC population can be effectively targeted by the combination of AZ + SFN. Our work portends clinical relevance and supports the therapeutic use of the novel AZ+ SFN combination that may target the TIC population of bronchial carcinoids. |
No. | Title | Href |
---|---|---|
1 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. BMC Cancer. 2019 Aug 30;19(1):864. doi: 10.1186/s12885-019-6018-1. | Click |